Virbac: H1 net income up 26%
(CercleFinance.com) - Virbac has reported a 26.
2% increase in H1 2024 net income (group share) to E94.7m, and a 3.4-point improvement in adjusted operating income before non-recurring items to a record 21.4% of sales.
The animal health group posted sales growth of 15.1% to E702.9m, up 11.3% LFL, driven by a combination of higher volumes and higher prices.
Virbac confirms its FY 2024 targets, including sales growth of 7% to 9% LFL, and adjusted operating income before non-recurring items of around 16%, compared with 15.1% in 2023.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
2% increase in H1 2024 net income (group share) to E94.7m, and a 3.4-point improvement in adjusted operating income before non-recurring items to a record 21.4% of sales.
The animal health group posted sales growth of 15.1% to E702.9m, up 11.3% LFL, driven by a combination of higher volumes and higher prices.
Virbac confirms its FY 2024 targets, including sales growth of 7% to 9% LFL, and adjusted operating income before non-recurring items of around 16%, compared with 15.1% in 2023.
Copyright (c) 2024 CercleFinance.com. All rights reserved.